Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021;14(5):543-549.
doi: 10.1159/000517851. Epub 2021 Sep 3.

Higher Levels of C-Reactive Protein and Ferritin in Patients with Overweight and Obesity and SARS-CoV-2-Related Pneumonia

Affiliations

Higher Levels of C-Reactive Protein and Ferritin in Patients with Overweight and Obesity and SARS-CoV-2-Related Pneumonia

Silvia Bettini et al. Obes Facts. 2021.

Abstract

Introduction: Overweight and obesity are associated with a more severe COronaVirus Disease 19 (COVID-19). Adipose tissue-related chronic inflammation could be a promoter for the occurrence of the cytokine storm that predicts aggravation of COVID-19. The primary aim was to investigate if this increased risk for more severe COVID-19 was associated with a higher inflammatory response.

Methods: We enrolled patients <75 years old hospitalized in a medical COVID-19 ward with SARS-CoV-2-related pneumonia. Patients were classified according to BMI as normal weight, overweight, and obesity. Laboratory parameters were measured at admission and every second day during the hospital stay.

Results: Ninety patients (64.4% males; median age 61 years) were enrolled. Invasive mechanical ventilation (IMV) was needed in 9% of the patients with normal weight, in 32.4% of the patients with overweight, and in 12.9% of the patients with obesity (p = 0.045). Maximal C-reactive protein (CRP) level during hospital stay was 92 (48-122) mg/L in patients with normal weight, 140 (82-265) mg/L in patients with overweight, and 117 (67-160) mg/L in patients with obesity (p = 0.037). Maximal ferritin values were 564 (403-1,379) μg/L in patients with a normal weight, 1,253 (754-2,532) μg/L in patients with overweight, and 828 (279-1,582) μg/L in patients with obesity (p = 0.015).

Conclusion: Patients with overweight and obesity required more IMV and had higher peaks of CRP and ferritin than patients with normal weight during COVID-19.

Keywords: C-reactive protein; Corona virus disease 19; Obesity; Overweight; Severe acute respiratory syndrome coronavirus.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Levels at Ad and max during hospitalization for CRP (A, B) and ferritin (C, D) in 90 patients hospitalized for SARS-CoV-2 related pneumonia. Patients were divided according to BMI into patients with a normal weight (BMI <25 kg/m2) (white bar), overweight (25 kg/m2 ≤ BMI <30 kg/m2) (gray bar), and obesity (BMI ≥30 kg/m2) (black bar). p value was determined by Kruskal-Wallis one-way analysis of variance on ranks. CRP, C-reactive protein; Ad, admission; max, maximal levels.

References

    1. Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, et al. Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev. 2020;21((11)):e13128. - PMC - PubMed
    1. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: Prospective Observational Cohort Study. BMJ. 2020;369:m1985. - PMC - PubMed
    1. Deng M, Qi Y, Deng L, Wang H, Xu Y, Li Z, et al. Obesity as a potential predictor of disease severity in young COVID-19 patients: a Retrospective Study. Obesity. 2020;28((10)):1815–25. - PMC - PubMed
    1. Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F, et al. Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission. Clin Infect Dis. 2020;71((15)):896–7. - PMC - PubMed
    1. Goossens GH, Dicker D, Farpour-Lambert NJ, Frühbeck G, Mullerova D, Woodward E, et al. Obesity and COVID-19: a perspective from the European Association for the Study of obesity on immunological perturbations, therapeutic challenges, and opportunities in obesity. Obes Facts. 2020;13((4)):439–52. - PMC - PubMed

Publication types